Clinical Trial Update: Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial comparing two dosing regimens of temozolomide in patients with progressive or recurrent glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Prof. Dr. Wolfgang Wick | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED